The protocol design is important as it dictates the way a study will be conducted.

Richmond Pharmacology’s Advanced Research Science Department has considerable experience in compiling Clinical Study Protocols according to ICH guidelines. Each protocol is developed in collaboration with the Sponsor in order to fulfil the trial requirements and objectives.

All protocols are written by Richmond Pharmacology’s Advanced Research Science team, with input from Richmond Pharmacology’s Research Physicians and Principal Investigators.

Our experienced Clinical Research Scientists will ensure your study design meets the specified end points by the most efficient method.

Get in touch today

Latest news

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Unlocking the potential of data sharing

January 4, 2023
Dilshat Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event